Sudarshan Pharma acquires Sudarshan Singapore shares

Sudarshan Pharma Industries (BSE: SUDARSHAN) announced today that it has acquired 10,000 ordinary shares of its Singapore-based subsidiary, Sudarshan Pharma Industries Private Limited, referred to as "Sudarshan Singapore." The acquisition, disclosed initially on November 29, 2024, was executed with Mr. Amar Ashok Vyas for a consideration of 10,000 Singapore Dollars, equivalent to INR 635,500. With this acquisition, Sudarshan Singapore now becomes a wholly-owned subsidiary of Sudarshan Pharma Industries, according to a stock filing. The acquisition was pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.